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Abstract
Introduction and hypothesis The aim of the British Society of Urogynaecology (BSUG) 2013 audit for stress urinary inconti-
nence (SUI) surgery was to conduct a national clinical audit looking at the intra- and postoperative complications and provide
outcomes for these procedures. This audit was supported by the Healthcare Quality Improvement Partnership (HQIP) and
National Health Service (NHS) England.
Methods Data were collected for all continence procedures performed in 2013 through the BSUG database. All clinicians in
England performing SUI surgery were invited to submit data to a central database. Outcomes data for the different continence
procedures were collected and included intraoperative and postoperative complications and the change in continence scores at
postoperative follow-up Changing trends in stress incontinence surgery were also assessed.
Results We recorded 4993 urinary incontinence procedures from 177 consultants at 110 centres in England: 94.6% were
midurethral slings; 86.7% (4331) were submitted by BSUG members with the remaining 13.3% submitted by non-BSUG
members. Postoperative follow-up data were available for 3983 (80%) patients: 92.3% (3676) were very much better/much
better postoperatively, and 4806 (96.3%) proceeded with no reported complications. There were 187 cases (3.7%) in which a
perioperative complication was recorded. Pain persisting >30 days was reported in 1.9% of all patients.
Conclusions Surgery for SUI has good outcomes in the short term. Midurethral synthetic slings have been shown to be safe and
effective as a treatment option, with >90% being very much/much better at their postoperative follow-up.
Keywords Stress urinary incontinence .Audit .Midurethral sling .Colposuspension .Urethral bulking .Autologous fascial sling
Introduction
In 2012, concerns about the use of vaginal mesh products in
incontinence and prolapse surgery were raised in the media
and subsequently in the Scottish Parliament and by National
Health Service (NHS) England. The British Society of
Urogynaecology (BSUG) collaborated with a number of or-
ganisations, including NHS England, the Royal College of
Obstetricians and Gynaecologists (RCOG) and the British
Association of Urological Surgeons (BAUS), and wrote to
all NHS trusts to address these concerns. This highlighted
the lack of available outcome data for individual surgeons
performing continence surgery. Although use of the BSUG
database was well established in many surgeons’ clinical prac-
tice, not all surgeons performing continence surgery were en-
tering their data on the database; many were not BSUG mem-
bers, and some were urological surgeons. To help address this
shortfall of information, NHS England, through the
Healthcare Quality Improvement Partnership (HQIP), wished
to support a national audit of stress incontinence surgery
through the Consultant Outcomes Publication (COP).
Professor Sir Bruce Keogh, NHSMedical Director at the time,
wrote to all medical directors to this effect. HQIP commis-
sioned BSUG to lead this audit, and all surgeons, both
gynaecologists and urologists, carrying out stress inconti-
nence surgery in England were expected to retrospectively
produce their personal results for the period 1 January 2013
to 31 December 2013, which would be analysed and pub-
lished. This was mandated only in England. Members in
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Wales, Northern Ireland and Scotland were not required to
take part in this process but were invited to enter their data
voluntarily if they so wished.
HQIP was established in April 2008. The main aim was to
promote quality in healthcare particularly aimed at increasing
the impact that clinical audit has on healthcare quality im-
provement. They are an independent organisation led by the
Academy of Medical Royal Colleges, The Royal College of
Nursing as well as National Voices. They commission, man-
age and support national and local programmes of quality
improvement.
The aim of the audit for stress urinary incontinence (SUI)
surgery was to conduct a national clinical audit of intra- and
postoperative complications and provide outcomes for these
procedures. Though individual outcomes for clinicians were
collected, assessing that data is out with the remit of this study.
Methods
An email was circulated by the executives of BSUG at that
time informing the membership of the intentions to complete
this audit through the BSUG database. An email was also sent
to medical directors of each NHS trust informing them of this
audit. This information was relayed by the governance leads
to all gynaecologists/urologists performing continence sur-
gery. An additional tab was created on the BSUG database
that covered all questions relating to this audit. For BSUG
members already using the database, there was little additional
work, as the database automatically populated the relevant
audit sections. They were, however, asked to check their data
entries to ensure it was accurate and complete. For BSUG
members not using the database, restricted access was granted
to allow retrospective data entry on the audit page. Non-
BSUG members undertaking continence surgery were given
access to the audit section of the database to allow registration
and data submission for the purposes of this audit.
The analysis included an assessment of all procedures un-
dertaken for urinary incontinence (UI). The grade of operator,
frequency with which urodynamics/cystometry was per-
formed preoperatively and concomitant procedures performed
were assessed. The risk of complications (intraoperative and
postoperative) were broken down by procedure and included
intraoperative complications and the need for catheterisation
>10 days, readmission to hospital within 30 days, graft com-
plications, pain persisting beyond 30 days and the Patient
Global Impression of Improvement (PGI-I) index were also
calculated. We also analysed the total number of these cases
performed in 2017 and compared trends in type of surgery
being performed with this audit data. All data were analysed
using SPSS 23 (Released 2015; IBM SPSS Statistics for
Windows, Version 23.0. Armonk, NY: IBM Corp). Simple
proportions were presented as percentages, mean and ranges
were performed in quantitative continuous data analysis, me-
dians and interquartile range (IQR) in quantitative discrete
data, and qualitative variables summarised using absolute
numbers and percentages.
Results
The audit of 2013 recorded 4993 cases input through the
BSUG data base. Procedures were recorded from 177 consul-
tants at 110 centres. Median number of cases per centre was 35
(range 1–174) and per consultant was 22 (range 1–173); 90.3%
(4507) of procedures were performed for primary SUI and
7.2% (360) for recurrent SUI. The average age of patients
undergoing surgery was 52.4 (18–95) years. Breakdown by
procedure is shown in Table 1. Seventeen cases of intravesical
botulinum were recorded and were thus excluded; in a further
48 cases, the procedure was not recorded. Synthetic
midurethral slings (MUS) accounted for 94.6% of recorded
procedures (4928). Retropubic midurethral synthetic tape was
the most commonly performed procedure, accounting for 3092
(62.7%) of the total number of cases, followed by the obturator
midurethral synthetic tape, which accounted for 1573 (31.9%).
Open/ laparoscopic colposuspension and autologous fascial
slings (AFS) accounted for a very small proportion of cases,
at 0.8% (40 cases).
Pelvic floor exercises were documented in 76% of patients,
and preoperative urodynamics were performed in 90%. Most
patients were seen by consultants (84.7%) who is a senior
hospital-based surgeon who has completed specialist training
and accepts ultimate responsibility for the care of the patients
referred to them. Most patients had no concomitant surgery
(2998; 60%). However, when additional procedures were per-
formed, anterior (527) and posterior repair (518) either in
Table 1 Procedures assessed in the Healthcare Quality Improvement
Partnership (HQUIP) audit
Procedure performed No. HQIP audit
2013 (4928)
No. HQIP
audit 2017
Retropubic midurethral sling 3092 1852
Obturator midurethral sling 1573 533
Single-incision sling 113 25
Bladder-neck injection 86 713
Open colposuspension 32 126
Laparoscopic colposuspension 8 85
Autologous fascial sling 16 61
Remeex (adjustable sling) 3 0
Diverticulum 2 x
Stamey 1 x
Anterior repair 1 x
Fistula 1 x
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isolation or in conjunction with other procedures were the
most commonly performed concurrently. Complications by
procedure are shown in Table 2. One hundred and eighty-
seven (3.7%) patients had a reported intraoperative complica-
tion or a return to theatre in the postoperative period. Reasons
included bladder injury, urethral injury, vaginal buttonholing,
vascular injury, nerve damage or the need for a blood transfu-
sion during hospital stay. There were no ureteric or bowel
injuries. The risk of bladder injury with a retropubic
midurethral synthetic tape was 3.6% (consultants 1.8%; other
operators 5.4%) but were reported with obturator tapes also,
albeit in very small numbers (0.2%). Major complications,
such as vascular injury, nerve damage and thromboembolism
were rarely reported (<0.1%) for any procedure.
The overall risk of catheterisation required after 10 days was
significantly greater with an AFS (43%) and colposuspension
(15%) when compared with a midurethral synthetic tape.
Postoperative follow-up data were available for 3983 (80%)
patients. Of these, 3676 (92.3%) patients themselves reported
theywere very much better/much better at their follow-up visit.
Results for individual procedures are shown in Table 3. The
follow-up visit was undertaken from 6 weeks to 12 months
after surgery, with most being at 3 months (38%). Pain
persisting >30 days was reported in 1.9% of all patients under-
going MUS but similar in retropubic and obturator MUS. Pain
was significantly higher in those undergoing an AFS (12.5%)
compared with a midurethral synthetic tape (1.9%), although
numbers were small (p < 0.01).
Graft complications were reported in 1.3% (39) of
retropubic synthetic tapes, 1.3% (22) of obturator synthetic
tapes and 0.8% (1) of single-incision synthetic tapes within
the follow-up period. Two deaths occurred during the study
period (one following a colposuspension and the other follow-
ing an obturator synthetic tape), but it was difficult to establish
causation. A considerable reduction in the number of synthetic
MUS insertions was reported that halved the number of these
procedures by 2017 (4781–2410). Whilst bladder-neck injec-
tions saw an eightfold increase (86–713), colposuspensions
(combined open and laparoscopic) increased fivefold (40–
211) and AFS fourfold (16–61) (Table 1). MUS continue
to account for >70% of SUI procedures.
Discussion
SUI has good outcomes in the short term. MUS have been
shown to be a safe and effective treatment option, with >90%
being very much/much better at postoperative follow-up.
Severe complications were rare, but small numbers for oper-
ations other than synthetic tapes made comparisons difficult.
There was a trend towards more complications (return to the-
atre, catheterisation >10 days, readmission, persisting pain Ta
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>30 days) in colposuspension and AFS. Pain was seen after
30 days in 1.9% of patients undergoing an MUS.
There are several reports from other registries, including
some stating their early results (Austrian registry) [1] then
going on to report large cohorts with longer-term follow-up
data [2]. Other countries, including The Netherlands [3, 4],
France [5], Norway [6] and Denmark [7], have published sin-
gle operation results or reviews of their whole database. In the
UK, there have been previous publications on various aspects
of the BSUG database [8]. The work we present here is dif-
ferent in that it describes the activity and risks of the different
SUI procedures over the period of 1 year. This allows trend
mapping and risk and complication identification of individ-
ual operations. Surgeons need comparative data when
counselling patients regarding risks and benefits of different
surgical procedures. Our report enables comparisons of differ-
ent procedures and their complications, and analyses will be
stronger when more data is available for operations performed
less commonly. Whilst using a whole database to identify a
single operation over a long time period is undoubtedly useful,
it includes surgeon learning curve of that procedure early in
the period. The initial aim of this audit was to provide yearly
outcome data for individual surgeons and analyse outcomes of
procedures for SUI, specifically, assessment of complications
such as pain. Providing COP data, however, is a costly and
labour-intensive process, and providing individual consultant
outcomes would require a significant investment from gov-
ernment to provide this information on an annual basis.
Other large data sets have been acquired using routinely
collected data such as Hospital Episode Statistics (HES data)
in England [9]. According to the recent NHS digital retrospec-
tive review of mesh procedures, in 2013–2014, 11,786 syn-
thetic tape surgeries were performed [10]. This data is depen-
dent on the accuracy of coding and does not provide any
information regarding patient outcome and is of limited value
in a clinical context. In addition, it is difficult to accurately
compare that data with this audit, as data captured through
HES is from April through March of the subsequent year,
whereas our data was from January through December.
Individual complications are difficult to identify, but longer-
term data sets are complimentary to the research described in
this paper. Such studies reported a 9.8% complication rate
after MUS surgery but did not define what those complica-
tions were. Many were related to voiding, which is a
recognised consequence of any continence surgery rather than
a complication. The type of data presented in our paper pro-
vides some of the information missing from HES data sets.
Large clinical data sets are useful for providing insight into
clinical practice and real-life outcomes, but they have limita-
tions. It has been recommended that all continence surgeons in
England use the BSUG database [11], but it is difficult to
mandate its use through the current commissioning process
for healthcare. It is difficult to be precise, but this audit of
gynaecologists collected almost 5000 cases from (probably)
8000 cases performed in that year by gynaecologists. The
follow-up of 80% was good. There is a risk or reporting bias
where users do not adequately record poor outcomes or com-
plications. Some users may not report all cases or may have
insufficient resources to chase full follow-up data. These are
issues common to all databases. Variable follow-up points for
outcomes may affect results. Long-term complications may be
missed with this type of yearly audit. The reporting of graft
complications in particular requires long-term follow-up.
Rates reported in this audit, at 1.3%, represent early compli-
cations that are likely to be a consequence of poor healing of
vaginal mucosa and midline exposure rather than mesh migra-
tion into adjacent organs, which may be detected with longer-
term follow-up. In 2017, the BSUG database was redesigned
to capture data relating to complications such as mesh remov-
al. Pain after 30 days was uncommon after MUS but was seen
in 1.9% of patients. Pain severity was not documented, and we
do not know if any further treatment was required for pain or
outcomes of any treatment.
Data presented in this paper provide information on a large
cohort of MUS synthetic tapes and suggest good success ac-
cording to the PGI-I scale and a low risk of complications.
Table 3 Outcomes by Patient Global Impression of Improvement (PGI-I) index, including pain
Procedure (n) Very much better/much
better/a little better
n (%)
A little better/
no change
n (%)
A little worse/much worse/
very much worse
n (%)
Pain after 30 days
n (%)
Retropubic synthetic tape (2391) 2213 (92.5) 160 (6.7) 18 (0.7) 56 (1.8)
Obturator synthetic tape (1329) 1242 (93.4) 80 (6.0) 7 (0.5) 33 (2)
Open colposuspension (27) 25 (92.6) 1 (3.7) 1 (3.7) 0
Laparoscopic colposuspension (6) 6 (100) 0 0 0
Autologous fascial sing (14) 13 (92.8) 1 (7.1) 0 2 (12.5)
Single-incision sling (94) 89 (94.6) 4 (4.3) 1 (1.1) 3 (2.6)
Bladder-neck injection (73) 45 (61.6) 27 (36.9) 1 (1.3) 0
Remeex (3) 2 (67) 1 (33) 0 0
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Major complications were uncommon. Other operations, such
as fascial slings and colposuspension, may have higher com-
plication rates, but more data is needed to establish this.
The BSUG is investigating the feasibility of analysing pa-
tients in the 2013 audit at the current time to see whether more
information can be obtained on longer-term outcomes related
to the use of synthetic mesh as well as failure and recurrence
rates of SUI surgery.
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